Callan Family Office LLC Buys Shares of 10,881 Ryan Specialty Holdings Inc. $RYAN

Key Points

• Callan Family Office LLC acquired 10,881 shares of Ryan Specialty Holdings Inc. valued around $740,000, reflecting growing institutional interest in the company.
• Ryan Specialty reported a 23% year-over-year increase in revenue with earnings per share of $0.66, matching analyst expectations in their latest earnings report.
• The company's recent quarterly dividend of $0.12 per share represents a 0.9% yield, with a payout ratio of 137.14%.

Callan Family Office LLC bought a new stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 10,881 shares of the company's stock, valued at approximately $740,000.

A number of other institutional investors and hedge funds have also bought and sold shares of RYAN. Principal Financial Group Inc. raised its position in Ryan Specialty by 66.4% during the 1st quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company's stock valued at $225,404,000 after purchasing an additional 1,218,147 shares in the last quarter. Invesco Ltd. raised its position in Ryan Specialty by 121.6% during the 1st quarter. Invesco Ltd. now owns 1,590,862 shares of the company's stock valued at $117,517,000 after purchasing an additional 872,846 shares in the last quarter. Artemis Investment Management LLP bought a new stake in Ryan Specialty during the 1st quarter valued at $57,023,000. Woodline Partners LP bought a new stake in Ryan Specialty during the 1st quarter valued at $40,278,000. Finally, Westfield Capital Management Co. LP raised its position in Ryan Specialty by 61.3% during the 1st quarter. Westfield Capital Management Co. LP now owns 1,078,233 shares of the company's stock valued at $79,649,000 after purchasing an additional 409,649 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

Ryan Specialty Stock Down 1.4%

Shares of RYAN stock opened at $54.45 on Tuesday. Ryan Specialty Holdings Inc. has a 1-year low of $50.08 and a 1-year high of $77.16. The stock's fifty day moving average price is $56.21 and its 200 day moving average price is $63.78. The company has a debt-to-equity ratio of 2.88, a current ratio of 1.01 and a quick ratio of 1.01. The company has a market cap of $14.36 billion, a price-to-earnings ratio of 155.58, a price-to-earnings-growth ratio of 1.54 and a beta of 0.63.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, hitting the consensus estimate of $0.66. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The firm had revenue of $855.17 million for the quarter, compared to the consensus estimate of $837.52 million. During the same period in the previous year, the business earned $0.58 EPS. The firm's revenue for the quarter was up 23.0% on a year-over-year basis. On average, research analysts expect that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.9%. The ex-dividend date was Tuesday, August 12th. Ryan Specialty's payout ratio is presently 137.14%.

Analysts Set New Price Targets

Several research firms have recently commented on RYAN. Weiss Ratings reissued a "hold (c-)" rating on shares of Ryan Specialty in a research report on Wednesday, October 8th. Morgan Stanley reduced their price target on Ryan Specialty from $68.00 to $65.00 and set an "overweight" rating for the company in a research report on Tuesday, October 7th. Wall Street Zen raised Ryan Specialty from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Barclays reissued an "overweight" rating and issued a $70.00 price target on shares of Ryan Specialty in a research report on Wednesday, October 8th. Finally, Wolfe Research raised Ryan Specialty to a "strong-buy" rating in a research report on Tuesday, September 16th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Ryan Specialty has a consensus rating of "Moderate Buy" and a consensus price target of $71.08.

Insiders Place Their Bets

In other news, Chairman Patrick G. Ryan purchased 276,634 shares of the company's stock in a transaction on Friday, September 12th. The shares were acquired at an average price of $51.84 per share, for a total transaction of $14,340,706.56. Following the purchase, the chairman owned 13,699,959 shares in the company, valued at $710,205,874.56. This trade represents a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 52.21% of the company's stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.